Loading...
 

Cardiac allograft vasculopathy

Cardiac Allograft Vasculopathy (CAV)


General: The most common cause of death among long-term survivors of cardiac transplantation. Occurs only in cardiac transplant recipients and is characterized by a form of accelerated atherosclerosis. Develops to some extent in ~58% of recipients within 1 year, and becomes clinically apparent in up to ~50% within 5 years. Treatment thus far has decreased the rates of rejection, but had no effect on rates of CAV.

Gross:

Microscopic: Concentric intimal proliferation/thickening involving intramyocardial vessels and exhibits few calcifications.

Differential Diagnosis:

Stains:
  • Positive:
  • Negative:
  • Suggested, focused panel:

((()))

Images:


Cases:



This site contains private study notes and is under construction, constant re-organization, and updating/correction. Although effort is made to ensure the accuracy of the contents, it should NOT be considered an authoritative medical reference. Thank you.

Created by kcshaw. Last Modification: Tuesday 16 of January, 2007 09:39:27 CST by kcshaw.

Newest Forum Posts